These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17657183)

  • 21. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
    Sugano M; Shintani Y; Kobayashi K; Sakakibara N; Isomura I; Morita A
    J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical tacrolimus for chronic actinic dermatitis.
    Suga Y; Hashimoto Y; Matsuba S; Mizoguchi M; Ogawa H
    J Am Acad Dermatol; 2002 Feb; 46(2):321-3. PubMed ID: 11807453
    [No Abstract]   [Full Text] [Related]  

  • 25. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
    Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
    Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of stasis dermatitis with topical tacrolimus.
    Dissemond J; Knab J; Lehnen M; Franckson T; Goos M
    Vasa; 2004 Nov; 33(4):260-2. PubMed ID: 15623206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.
    Carroll CL; Fleischer AB
    Expert Opin Pharmacother; 2004 Oct; 5(10):2127-37. PubMed ID: 15461548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Kang S; Lucky AW; Pariser D; Lawrence I; Hanifin JM
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S58-64. PubMed ID: 11145796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
    Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR
    J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis.
    Saripalli YV; Gadzia JE; Belsito DV
    J Am Acad Dermatol; 2003 Sep; 49(3):477-82. PubMed ID: 12963912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Paller AS; Stevens SR; Whitaker-Worth DL; Tong KB
    J Am Acad Dermatol; 2003 Apr; 48(4):553-63. PubMed ID: 12664019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
    Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrolimus ointment 0.1% for the treatment of peristomal skin disease: 3 case reports.
    Wells GL; Brown J; Manganiello WD; Chapman MS
    Cutis; 2006 Oct; 78(4):258-60. PubMed ID: 17121062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature.
    Pustisek N; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2002 Mar; 10(1):25-32. PubMed ID: 12137728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
    Ruzicka T; Bieber T; Schöpf E; Rubins A; Dobozy A; Bos JD; Jablonska S; Ahmed I; Thestrup-Pedersen K; Daniel F; Finzi A; Reitamo S
    N Engl J Med; 1997 Sep; 337(12):816-21. PubMed ID: 9295241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM; Plosker GL
    Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
    Rico MJ; Lawrence I
    Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.